Hence, confirming that pyruvate targets cPLA2 to mediate the regulation of metabolic syndrome including adiposity, meta-inflammation, and NAFLD in HFD-induced obesity. The gene discussed is PLA2G4A; the disease is metabolic dysfunction-associated steatotic liver disease.